Immune System Strength at Birth Linked to Quantity of Baby's Colds
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
The number of colds babies have in their first year of life can range from none to 10, a new study finds. And the quantity of colds was linked to the innate strength of the babies’ immune systems at birth.
The science of it is complex, but in a nutshell, the researchers extracted certain cells in blood from newborn’s umbilical cords, exposed those cells to a common respiratory virus (in a lab setting) and determined the strength of the responses.
The cells, called monocytes, are a type of white blood cell that fight infections. When they encounter a virus, the monocytes release a substance called interferon-gamma (IFN-gamma), which stops viruses from replicating.
Further research could lead to a method for boosting the immunity of babies who are born with weak ones.
“Ideally, if these results are confirmed, we would like to be able to intervene based on knowledge of the innate IFN-gamma response,” said Dr. Kaharu Sumino, assistant professor of medicine at Washington University School of Medicine in St. Louis. “We’re not there yet — measuring IFN-gamma levels is complex. But in the future, if we can develop a relatively easy way to find out if someone has a deficiency in this system, we would like to be able to give a drug that can boost the innate immune response.”
The research, announced today, is detailed in the May issue of the Journal of Allergy and Clinical Immunology. It involved 82 babies, mostly African-American, and all of which had at least one parent with allergies, asthma or eczema, putting them at higher risk for these conditions.
Get the world’s most fascinating discoveries delivered straight to your inbox.

